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Abstract
Background: Wound-related infection remains a major challenge for health professionals. One disadvantage in
conventional antibiotics is their inability to penetrate biofilms, the main protective strategy for bacteria to evade
irradiation. Previously, we have shown that synthetic antimicrobial peptides could inhibit bacterial biofilms
formation.
Results: In this study, we first delineated how Nal-P-113, a novel antimicrobial peptide, exerted its inhibitory effects
on Porphyromonas gingivalis W83 biofilms formation at a low concentration. Secondly, we performed gene
expression profiling and validated that Nal-P-113 at a low dose significantly down-regulated genes related to
mobile and extrachromosomal element functions, transport and binding proteins in Porphyromonas gingivalis W83.
Conclusions: These findings suggest that Nal-P-113 at low dose is sufficient to inhibit the formation of biofilms
although Porphyromonas gingivalis W83 may maintain its survival in the oral cavity. The newly discovered molecular
pathways may add the knowledge of developing a new strategy to target bacterial infections in combination with
current first-line treatment in periodontitis.
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Backgrounds
Periodontitis is one of the worldwide infectious diseases
in humans, with approximately half of the adults experi-
encing some degrees of chronic periodontitis in develop-
ing countries, while 15% of United Kingdom population
have developed severe periodontitis [1]. With an in-
crease in aging population, the problem becomes more
critical because elderly patients have compromised im-
mune systems which predispose them to a higher risk of
contracting bacterial infections. Reduced ability in tissue
repairing further substantiates the problem. Antibiotics
have been proven to work effectively against bacterial
infections. However, the overuse of drugs clearly drives
the evolution of bacteria resistance, endangering the effi-
cacy of antibiotics. Therefore there is an emergent need
to identify novel compounds to counteract bacterial in-
fections. In general, conventional antibiotics are unable
to penetrate biofilms. The formation of biofilms allows
the bacteria to anchor and propagate in the tissue.
Therefore, targeting the formation of biofilms may be a
new therapeutic option for periodontitis.
Previous studies have shown that synthetic antimicrobial
peptides inhibit bacterial biofilms formation. Numerous
studies have confirmed that the major antimicrobial pep-
tides mediated bactericidal mechanism is via rapid perfor-
ation of the cell membrane as well as activation of the
apoptotic program by interrupting the normal physio-
logical metabolism [2–4]. It has been demonstrated that
* Correspondence: yppan@cmu.edu.cn
1Department of Periodontics, School of Stomatology, China Medical
University, Shenyang 110002, China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wang et al. BMC Microbiology  (2017) 17:37 
DOI 10.1186/s12866-017-0948-z
antimicrobial peptide LL-37-treated Pseudomonas aerugi-
nosin showed enormous changes in its gene transcription,
with many de-regulated genes involved in the function of
flagellar [5]. Similarly, antimicrobial peptide 1037 treat-
ment for 24 h significantly changed the gene expression
profiles knowing to be regulated by LL-37 treatment
[6]. Nal-P-113, a modified version of antimicrobial
peptide P-113, its amino sequence is AKR-Nal-Nal-
GYKRKF-Nal-NH2. Antimicrobial peptide P-113 showed
promising antimicrobial effects against a variety of
pathogens [7–11]. Compared to P-113, Nal-P-113 main-
tained its effects when exposed to a high salt concentra-
tion and therefore it was an ideal candidate for
application in complicated matrices including oral
cavity, serum and plasma [12].
We have previously shown that Nal-P-113 exerts its
anti-bactericidal effects in a rat periodontitis model with a
significant reduction in tissue inflammation. Furthermore,
we have found that Nal-P-113 inhibits Porphyromonas
gingivalis (P. gingivalis) W83 biofilms formation. In this
study, we aimed to determine the effects of different
concentrations of Nal-P-113 in biofilms formation. Be-
sides, we performed gene expression profiles in Nal-P-
113-treated P. gingivalis W83 to delineate the underlying




P. gingivalis W83 was a gift from Professor RJ Lamont
(now in Department of oral Immunology and Infectious
Disease, School of Dentistry, University of Louisville) from
College of Dentist, University of Florida. Freshly prepared
brain heart infusion (BHI, Difco Laboratories, MI, USA)
agar medium supplemented with 5% sterile defibrinated
sheep’s blood, 1% hemin, and 0.1% menadione, was used
to grow P. gingivalis W83 at 37 °C under anaerobic condi-
tions (80% N2, 10% H2 and 10% CO2) for 5 to 7 days.
Reagents
Antimicrobial peptide Nal-P-113, Ac-AKR-Nal-Nal-
GYKRKF-Nal-NH2, was provided by Prof. Jiawei Cheng
in National Tsing Hua University [13]. H2O2 was pur-
chased from Sigma Aldrich (CA).
Bactericidal assay
P. gingivalis W83 was diluted to 5 × 105 CFU/mL (CFU,
colony forming units). The bacteria were treated with
Nal-P-113 in 100 μL culture medium for 24 h. Then an
aliquot (50 μL) of the resulting bacterial cell suspension
was cultivated on a brain heart infusion agar plate. The
bacterial cells were enumerated after incubation at 37 °C
for 7 days. All experiments were repeated three times.
Growth inhibition assay
P. gingivalis W83 culture was diluted to 5 × 105 CFU/
mL. The bacteria were treated with Nal-P-113 at differ-
ent concentrations (0, 5, 10, 20, 40, 80, 160 and 320 μg/
mL respectively) in 100 μL culture medium for 48 h.
The cell growth was measured by the absorbance at
600 nm in a microplate reader (Tecan Infini M200,
Switzerland). All experiments were repeated three times.
Scanning electron microscopy (SEM) analysis on Biofilms
Biofilms formation was quantified on 6-well plates (Corn-
ing, Netherlands) which were coated with artificial saliva
(Guangzhou Kodak Adhesives Co. Ltd., China). Five hun-
dred microliter of P. gingivalis W83 (5 × 106 CFU/mL)
with or without 6.25 μg/mL Nal-P-113 treatment was
dropped on 6-well plates and cultured for 48 h to establish
biofilms. Then, the samples were fixed with 2.5% glutaral-
dehyde (BioChemika, Fluka, USA), washed with PBS and
gradually dehydrated with ethanol. The processed samples
were smeared onto copper plates followed by gold sputter-
ing, and images were acquired using scanning electron
microscopy (Inspect F50, FEI Company, USA) at 20,000 ×
magnification.
Microarray hybridization
The total RNA of the bacteria treated with or without
6.25 μg/mL Nal-P-113 was extracted, converted to
cDNA, labeled with Cy3-dCTP (GE, Healthcare, CA)
and followed by hybridization with P. gingivalis W83
chip (Agilent, CA). Array hybridization, washing, scan-
ning and data analysis were performed at the CapitalBio
Corporation (Beijing, China).
Data analysis
The array data were analyzed with the GeneSpring software
V12 (Agilent). Significant genes were defined by following
criterions: FDR < 5% and fold change > 2 [14, 15].
Quantitative PCR (qPCR)
The total RNA of P. gingivalis W83 treated with or with-
out 6.25 μg/mL Nal-P-113 was reversed transcribed into
cDNA with the M-MLV RTase cDNA Synthesis Kit
(Takara, China). Real-time quantitative PCR reaction
was performed using SYBR Premix Ex TaqTM II PCR
Master Mix Reagents Kit (Takara). The primers for the
RT-qPCR were listed in Additional file 1: Table S1. qPCR
was performed three times for each sample. Relative
quantification of the mRNA levels was performed using
the comparative Ct method with the formula 2-ΔΔCt.
Hydrogen peroxide pre-treatment in P. gingivalis
P. gingivalis W83 was treated with H2O2 at different
concentrations (0, 0.5, 1, and 3 mM, respectively) for
1 h. The H2O2 was washed away with phosphate buffer
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saline before subsequent experiments. Total RNA of the
respective H2O2-treated P. gingivalis was extracted and
followed by RT-qPCR to determine the mRNA expres-
sion of PG0841, PG0842, PG0872, PG0874, PG0875,
PG1473, PG1474, PG1475, PG1478, PG1479, PG1482
and PG1485.
Biofilms susceptibility assay
3 mM H2O2 was used to change transposase genes
expression of P. gingivalis W83 for 1 h. The effect of
Nal-P-113 on P. gingivalis W83 biofilms formation was
examined using the microdilution method [12]. The
resulting biofilms were fixed with 95% methanol and
stained with 0.5% (w/v) crystal violet prior dissolving
with 95% ethanol and subjected to microplate reader at
absorption 590 nm. Percentage of inhibition was calcu-
lated using the equation [1-(A590 of the test/A590 of
non-treated control)] × 100. All experiments were re-
peated three times.
Enzyme linked immunosorbent assay (ELISA)
Lipopolysaccharide, free hemin and hemoglobin were
measured by commercial ELISA kit according to the re-
spective manual. Free hemin ELISA kit was purchase
from Abnova, Taiwan, and the hemoglobin ELISA kit
was purchased from Leagene, China. The measurements
were analysis by Curve Expert 1.3 (AL).
Statistical analysis
All experiments were performed in triplicate and repeated
at least three times. Data were expressed as means ±
standard deviations (SD). ANOVA and independent sam-
ples t-test were used to calculate the significance among
the groups (SPSS Inc., IL, USA). P-value < 0.05 was con-
sidered statistically significant.
Results
The antibacterial activity of Nal-P-113 against P. gingivalis
W83
P. gingivalis W83 is one of the major pathogenic species
in dental plaque biofilms. Firstly, we examined the in-
hibitory effects of Nal-P-113 on P. gingivalis W83 bio-
films formation. Consistent with our previous study,
6.25 μg/mL Nal-P-113 significantly inhibited P. gingivalis
W83 biofilms formation (Fig. 1a). The biofilms inhibi-
tory effect of Nal-P-113 was further validated with scan-
ning electron microscopy (SEM) (Fig. 1b). Before treated
with Nal-P-113, the bacteria engaged with each other
and resulted in the formation of biofilms. Upon
6.25 μg/mL Nal-P-113 treatment, the bacteria contin-
ued to divide and were unable to fuse together, there-
fore inhibited the formation of biofilms. Conversely,
treatment with 320 μg/mL Nal-P-113 resulted in a
complete breakdown of the bacteria structure. Secondly,
we evaluated the antibacterial activity of Nal-P-113 against
planktonic P. gingivalis W83. Results showed that Nal-P-
113 at a low concentration exhibited neither bactericidal
activity nor growth inhibitory effect against P. gingivalis
W83 (Fig. 1c, d). These results suggested that Nal-P-113
at high concentrations inhibited biofilms formation by
direct killing of the bacteria, whereas Nal-P-113 at a low
concentration adopted an alternative mechanism to
inhibit the formation of biofilms in P. gingivalis W83.
Nal-P-113 induced differential gene expression and
disrupted the signaling pathways in P. gingivalis W83
To further understand the underlying mechanism of
Nal-P-113-inhibited biofilms formation in P. gingivalis
W83, we exposed the P. gingivalis W83 with 6.25 μg/mL
Nal-P-113 for 0.5 h prior subjected to microarray gene
analysis. Genes with expression fold change greater than
2 and FDR < 5% were identified as dysregulated genes.
Supervised clustering analysis showed that Nal-P-113
treatment induced a significant alternation of gene ex-
pression in P. gingivalis W83 compared to untreated
control (Fig. 2a). In total, Nal-P-113 treatment resulted
in an increase in 204 transcripts and a decrease in 220
transcripts in P. gingivalis W83 (Additional file 1: Table
S2). The complete list of gene expression values has
been deposited in NCBI’s Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE 93873).
Although the genome of P. gingivalis W83 was pub-
lished more than a decade ago, little is known about the
interconnections among signaling pathways and how the
interplay may impact the therapeutic interventions. We
input the genes that were differentially expressed after
Nal-P-113 treatment to STRING database for KEGG
pathway analysis. Differentially regulated genes can be
categorized into six groups according to the TIGR gen-
ome database. Majority of the dysregulated genes were
involved in one of the following cellular functions/path-
ways: mobility and extrachromosomal element functions,
energy metabolism, cell envelope, transport and binding
proteins, protein synthesis and protein fate. Interestingly,
dysregulated genes that were found to be involved in the
down-regulated pathways were mainly related to mobil-
ity, extrachromosomal element functions as well as
transport and binding protein. Meanwhile, differentially
expressed genes involved in the up-regulated pathways
were associated to cell envelope, energy metabolism,
protein fate and synthesis (Fig. 2b and c).
Following, we selected the top 12 up-regulated and
down-regulated genes (Additional file 1: Table S3) from
the microarray analysis for validation. Apart from the
dysregulated genes, we also included four additional
genes whose expressions were not altered by Nal-P-113
as negative control. All top 6 up-regulated and down-
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regulated genes showed a similar trend and fold change
in expression levels between microarray analysis and
quantitative PCR, with a correlation value (R) of 0.964
(Fig. 2d and e).
The biological effect of dysregulated genes and pathways
after Nal-P-113 treatment
To further verify the underlying mechanism in Nal-P-
113-treated P. gingivalis W83, we first used ELISA to
detect free hemin and hemoglobin in liquid BHI. In ac-
cordance with the down-regulation of hmuY (PG1551)
and HmuR (PG1552), known as proteins involved in the
uptake of nutrients in a bacterial system (Fig. 3a), we ob-
served a significant decrease in heme but not
hemoglobin in the Nal-P-113-treated P. gingivalis W83
(Fig. 3b and c). Besides, when 3 mM H2O2 induced the
expression of the transpoases genes that were found to
be down-regulated by Nal-P-113 (Fig. 3d), 6.25 μg/mL
Nal-P-113 did not inhibit P. gingivalis W83 biofilms
formation (Fig. 3e). The result suggested that the trans-
poase pathways played a role in the Nal-P-113-regulated
biofilms formation in P. gingivalis W83.
Discussion
P. gingivalis is a Gram-negative oral anaerobe that has
been known to play a major role in the pathogenesis of
periodontitis. P. gingivalis, presents within the forming
biofilms, orchestrates the virulence of the biofilms and
consequent tissue inflammatory response to destroy the
gingival tissues and ultimately resulting in tooth loss.
Previously, we and others have shown that synthetic
antimicrobial peptides can inhibit bacterial biofilms for-
mation [12]. Multiple lines of evidence suggested that
antimicrobial peptides acted via rapid perforation of the
cell membrane [2–4]. Nevertheless, our SEM image
showed that the cell membrane structure remained in-
tact after treatment of 6.25 μg/mL Nal-P-113, indicating
that a low concentration of Nal-P-113 did not disrupt
the bacteria membrane. Nevertheless, Nal-P-113 at a
low dose may still have indirect effects on bacterial
membrane. For example, PG0192 and PG0193, encoding
the cationic outer membrane proteins that involve in the
colonization and biofilms formation, were both down-
regulated by 2.15 fold and 2.07 fold, respectively, upon
Nal-P-113 treatment. In parallel, PG2133 encoding lipo-
protein was down-regulated by 2.50 fold. The Gram-
negative bacterial lipoprotein is an essential component
of the outer membrane, which plays a key role in bacter-
ial infection, survival, as well as invading and damaging
the host’s immune defense. The down-regulation of
PG0192, PG0193 and PG2133 may be correlated with
the effects of antimicrobial peptides in the bacterial
membranes that reduce their ability to maintain cellular
structure, to form biofilms or to survive.
Studies have reported the inhibiting effects of anti-
microbial peptides in biofilms formation, which involved
the disruption of the bacteria’s physiological metabolism
[2–4]. However, our gene expression profiling demon-
strated that the presence of Nal-P-113 enhanced P.
gingivalis W83 aerobic respiration to survive. There
were 23 differentially expressed genes function in energy
metabolism, five genes were down-regulated, and 18
Fig. 1 The MIC of Nal-P-113 to P. gingivalis W83 was 160 μg/mL, the MBC was 20 μg/mL, the MBIC was 6.25 μg/mL. The above results showed
that Nal-P-113 inhibited P. gingivalis biofilms at a concentration that did not inhibit P. gingivalis growth. a Biofilms susceptibility assay of Nal-P-113
against P. gingivalis W83. b SEM image of P. gingivalis W83 in biofilm formation. c Bacterial growth assay of Nal-P-113-treated P. gingivalis W83. d
Bactericidal assay of Nal-P-113-treated P. gingivalis W83. Data shown here are the mean ± S.D. from three independent cultures
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genes were up-regulated. Cytochrome dubiquinol oxidase-
encoding genes, cydA (PG0900) and cydB (PG0899),
which are related to aerobic respiration in P. gingivalis
[16], were up-regulated by 3.64-fold and 2.06–fold, re-
spectively. Within the locus encoding cydA and cydB,
there is an open reading frame encoding a protein of un-
known function (PG0901), and was up-regulated in the
presence of Nal-P-113, indicating that it may be a member
of the same transcriptional unit as the cydAB operon.
PG0130, encoding the phosphoglycerate mutase that par-
ticipates in DNA and RNA synthesis, was up-regulated.
Furthermore, genes related to protein synthesis were up-
regulated. PG0502, encoding SsrA-binding protein, was
up-regulated by 2.61-fold. PG0992, encodes threonyl-
tRNA synthetase, PG1132 encodes valyl-tRNA synthetase,
and PG2165 encodes glycyl-tRNA synthetase, were found
to be up-regulated. Ammonia acyl-tRNA synthetase is one
of the key enzymes in protein synthesis [17]. PG2117 and
PG0990 both encoding ribosomal proteins were shown to
be up-regulated by 3.32-fold and 2.52-fold, respectively.
Moreover, transporting and binding protein pathway
was also significantly inhibited by Nal-P-113 treatment. 4
out of the 25 transporting and binding protein-related
genes were up-regulated, and the remaining 19 genes were
down-regulated. PG0282 and PG1663 encode ABC trans-
porter and ATP-binding protein, respectively. PG0281,
PG0280, PG1664 and PG1665, encoding ABC transporter
and permease proteins, were down-regulated. ABC trans-
porters are a group of transmembrane proteins, known to
be associated with a variety of physiological processes
Fig. 2 Differentially gene expression was exhibited in Nal-P-113-treated Porphyromonas gingivalis W83 as shown in KEGG pathway analysis. Differentially
regulated genes can be categorized into six groups according to the TIGR genome database, including mobility and extrachromosomal element functions,
energy metabolism, cell envelope, transport and binding proteins, protein synthesis and protein fate. 12 genes were selected to verify the consistency of
quantitative PCR and Microarray analysis. a Supervised clustering of Nal-P-113-treated and non-treated Porphyromonas gingivalis (n= 3); (b) KEGG pathway
analysis on the deferentially expressed genes in Nal-P-113-treated Porphyromonas gingivalis. c The network was constructed in the six major dys-regulated
pathways. a: Differentially expressed genes related to mobile and extrachromosomal element functions. b: Differentially expressed genes
related to energy metabolism. c: Differentially expressed genes related to cell envelope. d: Differentially expressed genes related to transport
and binding protein. e: Differentially expressed genes related to protein synthesis. f: Differentially expressed genes related to protein fate. Nodes and edges
represent differentially expressed genes and interactions among them. Up-regulated genes were represented as pink nodes, down-regulated genes were
represented as green nodes. d The fold changes of gene expression levels in Porphyromonas gingivalis after Nal-P-113 treatment. Data shown here are the
mean ± S.D. from three independent cultures. *, P< 0.05; **, P< 0.01. e Correlation of the expression fold change between quantitative PCR and microarray.
Green, down-regulated genes, Black, unaffected genes, Red, up-regulated genes
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including the uptake of nutrients, the non-classical secre-
tion of signaling molecules and toxins, multidrug resist-
ance and the development of human disease. ABC
transporters play a role in cell-to-surface and cell-to-cell
interactions in biofilms development [18–20]. The ob-
served differentially expressed genes in ABC transporter
superfamily were in line with our SEM result, demonstrat-
ing the loss of cell contact in P. gingivalis W83 after
treated with Nal-P-113 at a low concentration.
PG2016, encoding CRISPR-associated helicase, PG1985,
PG1986 and PG1987 encoding other CRISPR-associated
proteins, were shown to be up-regulated and may be re-
lated to the immune response due to foreign DNA. The
down-regulation in integrase and the up-regulation of
CRISPR-associated proteins indicated that the killing of P.
gingivalis W83 by Nal-P-113 differed to that of antibiotics.
Therefore, the acquisition of resistance to Nal-P-113 is
less likely compared to antibiotic since different mecha-
nisms are activated in the bacteria system.
Lastly, PG1551 encodes hmuY protein, while PG1552
encodes the TonB-dependent receptor HmuR. These
two genes were down-regulated by 2.39-fold and 3.67-
fold, respectively. The bacterial uptake system for heme
requires two kinds of proteins: HmuY, which scavenges
heme from host hemoproteins, and HmuR, which trans-
ports nutrients across the bacterial cell membrane. The
down-regulation of these two genes by Nal-P-113 sug-
gested that Nal-P-113 treatment might weaken the abil-
ity of P. gingivalis W83 to utilize hemin. In fact, our
ELISA assays verified that the concentration of hemin
decreased significantly in the Nal-P-113-treated P. gingi-
valis W83 liquid BHI, indicating that Nal-P-113-treated
bacteria could not utilize the hemin efficiently, therefore
inhibited the formation of biofilms. Furthermore,
PG0841, PG0842, PG0872, PG0874, PG0875, PG1473,
PG1474, PG1475, PG1478, PG1479, PG1482, PG1485,
which encode the transposase genes were all down-
regulated upon Nal-P-113 treatment. Previous studies
have shown that H2O2 induces the expression of trans-
posase genes in P. gingivalis [21, 22]. Our results showed
that H2O2 pre-treatment abolished 6.25 mg/mL Nal-P-
113 anti-biofilms formation in P. gingivalis W83, which
indicated that transposase genes played an important
role in Nal-P-113-mediated biofilms formation.
Conclusions
P. gingivalis is one of the major etiologic agents which
contributes to chronic periodontitis. It attributes to the
formation of subgingival biofilms and stimulates a cascade
of inflammatory reaction. Our results showed that Nal-P-
113 exerted its anti-microbial and anti-biofilms effects in
P. gingivalis W83 by mediating the energy metabolism,
protein synthesis, mobile and extrachromosomal element
functions, transport and binding proteins of the bacteria.
In addition, we verified that Nal-P-113 acted through the
down-regulation of transposase genes or reduction of he-
min utilization in P. gingivalis W83 to inhibit the forma-
tion of biofilms. In summary, this study provides a
molecular biological basis of Nal-P-113 in the prevention
and treatment of periodontitis.
Fig. 3 Validation of biological effect according to gene expression profiling analysis. a The fold changes of PG1151 and PG1152 gene expression
levels in Porphyromonas gingivalis after Nal-P-113 treatment. b Free hemin concentration in P. gingivalis W83 culture medium either with or without
treatment of Nal-P-113. c Hemoglobin concentration in P. gingivalis W83 culture medium either with or without treatment of Nal-P-113. d The expression
of transposases levels in Porphyromonas gingivalis after 3 mM H2O2 treatment for one hour. e Biofilm susceptibility assay of Nal-P-113-treated P. gingivalis
W83 with or without H2O2 pretreatment. Data shown here are the mean ± S.D. from three independent cultures, *, P< 0.05, **, P< 0.01
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Additional file
Additional file 1: Table S1. List of primers used for qPCR experiments.
Table S2. Up-regulated gene list in Nal-P-113 treated P.gingivalis W83
(hypothetical protein excluded). Table S3. Down-regulated gene list in
Nal-P-113 treated P.gingivalis W83 (hypothetical protein excluded). (DOCX 46 kb)
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